Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 162Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Aspen Pharmacare Holdings

02 8Strides Pharma Science

03 2Adcock Ingram

04 2Alphapharm PTY Ltd

05 2Alvogen

06 2Apotex Inc

07 1Auro Pharma Inc

08 9Aurobindo Pharma Limited

09 25Boehringer Ingelheim GmbH

10 8Cipla

11 5Cipla Medpro South Africa

12 6Emcure Pharmaceuticals

13 6Hetero Drugs

14 1JAMP PHARMA

15 1LeBasi Pharmaceuticals CC

16 2MATRIX LABORATORIES XIAMEN LTD.

17 5Macleods Pharmaceuticals Limited

18 1Mepha Pharma

19 2Micro Labs Limited

20 2NORVIUM BIOSCIENCE

21 2Novagen Pharma

22 4Orbit Lifescience

23 2Pharmacare Premium

24 1Pharmascience Inc.

25 1Prime Pharmaceuticals

26 1Prinston

27 3RANBAXY LABORATORIES LIMITED

28 3Sandoz B2B

29 2Smith & Kenner Pharmaceuticals

30 1Stellapharm

31 3TECH ORGANIZED

32 2Teva Pharmaceutical Industries

33 3Varichem Pharmaceuticals Pvt Ltd

34 10Viatris

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed

Nevirapine

Brand Name : Aspen Nevirapine 200Mg

Dosage Form : TAB

Dosage Strength : 200mg

Packaging : 60X1mg

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

Aspen API Comapny Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info :

Registration Country : USA

STAVUDINE; LAMIVUDINE; NEVIRAPINE

Brand Name : STAVUDINE; LAMIVUDINE; NEVIRAPINE

Dosage Form : TABLET; ORAL

Dosage Strength : 40MG; 150MG; 200MG

Packaging :

Approval Date :

Application Number : 21837

Regulatory Info :

Registration Country : USA

Strides Pharma Science

03

arrow
2024 ACI Convention
Not Confirmed

Nevirapine

Brand Name : Aspen Nevirapine Suspension

Dosage Form : SUS

Dosage Strength : 50mg/5ml

Packaging : 240X1mg/5ml

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

Aspen API Comapny Banner

04

arrow
2024 ACI Convention
Not Confirmed

Nevirapine

Brand Name : Virtrium 30/150/200

Dosage Form : TAB

Dosage Strength : 200mg

Packaging : 60X1mg

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

Aspen API Comapny Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info :

Registration Country : USA

STAVUDINE; LAMIVUDINE; NEVIRAPINE

Brand Name : STAVUDINE; LAMIVUDINE W/NEVIRAPINE

Dosage Form : TABLET; ORAL

Dosage Strength : 40MG; 150MG; 200MG

Packaging :

Approval Date :

Application Number : 21854

Regulatory Info :

Registration Country : USA

Strides Pharma Science

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info :

Registration Country : USA

LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE

Brand Name : Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets

Dosage Form : TABLET; ORAL

Dosage Strength : 150MG; 300MG; 200MG

Packaging :

Approval Date :

Application Number : 21988

Regulatory Info :

Registration Country : USA

Strides Pharma Science

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info :

Registration Country : USA

STAVUDINE; LAMIVUDINE; NEVIRAPINE

Brand Name : STAVUDINE; LAMIVUDINE; NEVIRAPINE

Dosage Form : TABLET; ORAL

Dosage Strength : 30MG; 150MG; 200MG

Packaging :

Approval Date :

Application Number : 22177

Regulatory Info :

Registration Country : USA

Strides Pharma Science

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info :

Registration Country : USA

LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE

Brand Name : LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE

Dosage Form : TABLET; ORAL

Dosage Strength : 150MG; 200MG; 300MG

Packaging :

Approval Date :

Application Number : 22464

Regulatory Info :

Registration Country : USA

Strides Pharma Science

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info : RX

Registration Country : USA

NEVIRAPINE

Brand Name : NEVIRAPINE

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG

Packaging :

Approval Date : 2012-05-22

Application Number : 78195

Regulatory Info : RX

Registration Country : USA

Strides Pharma Science

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info :

Registration Country : USA

LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE

Brand Name : LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE

Dosage Form : TABLET, FOR SUSPENSION; ORAL

Dosage Strength : 30MG; 50MG; 60MG

Packaging :

Approval Date :

Application Number : 202685

Regulatory Info :

Registration Country : USA

Strides Pharma Science

11

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info :

Registration Country : India

Nevirapine

Brand Name :

Dosage Form : Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE

Brand Name : Lamivudine, Zidovudine, Nevirapine Tabs 150mg/300mg/200mg

Dosage Form : TABLET; ORAL

Dosage Strength : 150MG; 300MG; 200MG

Packaging :

Approval Date :

Application Number : 21939

Regulatory Info :

Registration Country : USA

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

NEVIRAPINE

Brand Name : NEVIRAPINE TABLETS FOR ORAL SUSPENSION

Dosage Form : TABLET; ORAL

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 22299

Regulatory Info :

Registration Country : USA

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

NEVIRAPINE

Brand Name : VIRAMUNE

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG

Packaging :

Approval Date : 1996-06-21

Application Number : 20636

Regulatory Info : DISCN

Registration Country : USA

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

NEVIRAPINE

Brand Name : VIRAMUNE

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 50MG/5ML

Packaging :

Approval Date : 1998-09-11

Application Number : 20933

Regulatory Info : DISCN

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE

Brand Name : LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE

Dosage Form : TABLET; ORAL

Dosage Strength : 150MG; 300MG; 200MG

Packaging :

Approval Date :

Application Number : 21971

Regulatory Info :

Registration Country : USA

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

STAVUDINE; LAMIVUDINE; NEVIRAPINE

Brand Name : STAVUDINE; LAMIVUDINE; NEVIRAPINE

Dosage Form : TABLET; ORAL

Dosage Strength : 30MG; 150MG; 200MG

Packaging :

Approval Date :

Application Number : 22342

Regulatory Info :

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

STAVUDINE; LAMIVUDINE; NEVIRAPINE

Brand Name : STAVUDINE; LAMIVUDINE; NEVIRAPINE

Dosage Form : TABLET; ORAL

Dosage Strength : 40MG; 150MG; 200MG

Packaging :

Approval Date :

Application Number : 22342

Regulatory Info :

Registration Country : USA

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE

Brand Name : LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE

Dosage Form : TABLET; ORAL

Dosage Strength : 150MG; 200MG; 300MG

Packaging :

Approval Date :

Application Number : 22061

Regulatory Info :

Registration Country : USA

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

STAVUDINE; LAMIVUDINE; NEVIRAPINE

Brand Name : STAVUDINE; LAMIVUDINE; NEVIRAPINE

Dosage Form : TABLET; ORAL

Dosage Strength : 30MG; 150MG; 200MG

Packaging :

Approval Date :

Application Number : 22346

Regulatory Info :

Registration Country : USA

blank